TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 2 | P.d | 10,935 | 2.93 | 0 | 3,735 | 43 | 12,489 | M | ||||||||||||||
5/13/24 18:00 | 5/9/24 | STAA | Staar Surgical Co | DE | Health | OthMd | Ophthalmic Goods | 1 | 10 | P.m | 69,216 | 34.86 | 0 | 1,985 | 10 | 21,563 | M | ||||||||||||||
2/8/24 18:58 | 2/6/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | 1 | 1 | P | 7,000 | 1.04 | 0 | 6,731 | 9 | 83,420 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |